Medtech Firms Practice Watchful Waiting In Brexit Fallout
This article was originally published in Clinica
Executive Summary
Amidst the uproar that followed the Brexit vote on June 23, one clear message that has emerged from the life sciences sector is that a future EU-independent UK – and the path to getting there – is not good news.